AstraZeneca has breached the UK pharmaceutical industry's code of practice, an industry self-regulatory body ruled on Friday, ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is initiating a Phase 2 ...

The FDA has accepted for review Chiesi’s New Drug Application (NDA) for their investigational maintenance treatment for ...

The new tool, available as a phone app, helps identify comorbidities and produces a score to guide clinicians.

Fundamental changes in asthma management are all geared to breaking the inhalers-antibiotics-inhalers-steroids cycle ...

Each patient using inhalers with propellants in 2023 produced 140kg of CO2 emissions over a year. Read more at ...

For many years, treatment of asthma has focused on symptom management and control. As the understanding of disease processes has improved and treatments begin to target underlying mechanisms, there is ...

Adding home remedies on top of your prescribed asthma medications can help you fight inflammation and remove stale air from your lungs.

Discover how glucocorticoid-mediated eosinopoiesis in asthma creates a paradox, influencing relapse, steroid resistance, and ...

Respiratory diseases such as Asthma and Chronic Obstructive Pulmonary Disease (COPD) are on the rise partly because of ...

Chiesi USA's asthma inhaler could simplify treatment for millions of Americans. Triangle Forward: What's Next for Life Sciences?

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s recent clinical study, officially titled ...